TY - JOUR T1 - Bacteremia in non-HIV community acquired pneumonia JF - European Respiratory Journal JO - Eur Respir J VL - 42 IS - Suppl 57 SP - P289 AU - Catia Cilloniz AU - Antoni Torres AU - Eva Polverino AU - Miquel Ferrer AU - Albert Gabarrus AU - Jordi Almirall AU - Santiago Villegas AU - Beatriz Montull AU - Frances Marco AU - Josep Mensa AU - Rafael Zalacain AU - Albert Capelastegui AU - Javier Aspa AU - Luis Borderias AU - Michael Niederman AU - Rosario Menendez AU - NAC CALIDAD Study Group Y1 - 2013/09/01 UR - http://erj.ersjournals.com/content/42/Suppl_57/P289.abstract N2 - Background: Many current guidelines recommend the collection of two sets of blood cultures in all hospitalized patients with community acquired pneumonia (CAP), even though blood cultures are positive in less than 15% of cases. A number of studies have suggested that bacteremia is a risk factor for death in patients with CAP. We aimed to determine the incidence, microbial etiology and risk factors and outcomes of bacteremic patients with CAP non-HIV.Methods: Prospective observational study of consecutive patients seen in the ED with the diagnosis of CAP, whose blood cultures were obtained in the ED. Nursing home patients were excluded.Results: We studied 5346 patients with CAP,bacteremia was present in 576(11%). Independent predictors of bacteremia in multivariate analysis were female sex, pleuritic pain, C-reactive protein ≥22 mg/dL, PSI risk classes IV-V, and ICU admission.Prior antibiotic treatment was a protective factor. SKAPE (S aureus, K pneumoniae, A baumannii, P aeruginosa and Enterobacteriaceae) but not pneumococcal bacteremia was an independent predictor of 30-day hospital mortality in multivariate analysis.Conclusions: We identified important risk factors to predict bacteremia on admission with CAP. We believe that these factors can be useful for future guidelines to better define which CAP patients would benefit from blood cultures and from more intensive monitoring. ER -